Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart

Journal of the American College of Cardiology

Volumn 32, Issue 4, 1998, Pages 955-963

  Drexler, Helmut ^a   Kästner, Stephanie ^a   Strobel, Armin ^a   Studer, Roland ^a   Brodde, Otto E ^b   Hasenfuß, Gerd ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPRENALINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME ASSAY; GENE EXPRESSION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; INOTROPISM; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADRENERGIC BETA-AGONISTS; ENZYME INHIBITORS; HEART FAILURE, CONGESTIVE; HUMANS; ISOPROTERENOL; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIUM; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OMEGA-N-METHYLARGININE; POLYMERASE CHAIN REACTION; STIMULATION, CHEMICAL; TRANSCRIPTION, GENETIC;

EID: 0032192130     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00336-2     Document Type: Article

References (40)

1. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. New Engl J Med. 329:1993;2002-2012.
2. Bredt D.S., Snyder S.H. Nitric oxide a physiologic messenger molecule . Annu Rev Biochem. 63:1994;175-195.
3. Brutsaert D.L., Meulemans A.L., Sipido K.R., Sys S.U. Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle. Circ Res. 62:1988;357-366.
4. Finkel M.S., Oddis C.V., Jacob T.D., Watkins S.C., Hattler B.G., Simmons R.L. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 257:1992;387-389.
5. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol. 105:1992;575-580.
6. Balligand J.L., Kelly R.A., Marsden P.A., Smith T.W., Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci USA. 90:1993;347-351.
7. Gulick T., Chung M.K., Pieper S.J., Lange L.G., Schreiner G.F. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness. Proc Natl Acad Sci USA. 86:1989;6753-6757.
8. Suffredini A.F., Fromm R.E., Parker M.M., et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med. 321:1989;280-287.
9. Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in congestive heart failure. N Engl J Med. 323:1990;236-241.
10. Torre-Amione G., Kapadia S., Lee J., et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation. 93:1996;704-711.
11. de Belder A.J., Radomski M.W., Why H.J.F., et al. Nitric oxide synthase activities in human myocardium. Lancet. 341:1993;84-85.
12. Haywood G.A., Tsao P.S., von der Leyen H., et al. Expression of inducible nitric oxide synthase in human failing heart. Circulation. 93:1996;1087-1094.
13. Paulus W.J., Vantrimpont P.J., Shah A.M. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Circulation. 89:1994;2070-2078.
14. Hare J.M., Loh E., Creager M.A., Colucci W.S. Nitric oxide inhibits the positive inotropic response to β-adrenergic stimulation in humnas with left ventricular dysfunction. Circulation. 92:1995;2198-2203.
15. Mulieri L.A., Hasenfuss G., Ittleman F., Blanchard E.M., Alpert N.R. Protection of human left ventricular myocardium from cutting injury with 2,3-butanedione monoxime. Circ Res. 65:1989;1441-1444.
16. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanat-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
17. Studer R., Reinecke H., Müller B., Holtz J., Just H.J., Drexler H. Increased angiotensin-I converting enzyme gene expression in the failing human heart. J Clin Invest. 94:1994;301-310.
18. Marsden P.A., Schappert K.T., Chen H.S., et al. Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett. 307:1992;287-293.
19. Geller D.A., Lowenstein C.J., Shapiro R.A., et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci. 90:1993;3491-3495.
20. Radomski M.W., Vallance P., Whitley G., Foxwell N., Moncada S. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc Res. 27:1993;1380-1382.
21. Schranz D., Droege A., Broede A., et al. Uncoupling of human cardiac β-adrenoceptors during cardiopulmonary bypass with cardioplegic cardiac arrest. Circulation. 87:1993;422-426.
22. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
23. 2-adrenoceptors . Eur J Pharmacol. 130:1986;137-139.
24. 2+-ATPase in failing and nonfailing human myocardium. Circ Res. 75:1994;434-442.
25. de Belder A.J., Radomski M.W., Why H.J., Richardson P.J., Martin J.F. Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomypathy, myocarditis and postpartum cardiomyopathy but not in ischaemic or valvar heart disease. Br Heart J. 74:1995;426-430.
26. Habib F.M., Springall D.R., Davies G.J., Oakley C.M., Yacoub M.H., Polak J.M. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet. 347:1996;1151-1155.
27. Balligand J.L., Ungureanu-Longrois D., Simmons W.W., et al. Cytokine-inducible nitric oxide synthase (NOS II) expression in cardiac myocytes. J Biol Chem. 269:1994;27580-27588.
28. Kichuk M.R., Seyedi N., Zhang X., et al. Regulation of nitric oxide production in human coronary microvessels and the contribution of local kinin formation. Circulation. 94:1996;44-51.
29. Treasure C.B., Vita J.A., Cox D.A., et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation. 81:1990;772-779.
30. Drexler H., Zeiher A.M. Endothelial function in human coronary arteries in vivo. Hypertension. 18:(Suppl II):1991;II90-II99.
31. Grocott-Mason R., Anning P., Evans H., Lewis M.J., Shah A.M. Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide. Am J Physiol. 267:1994;H1804-H1813.
32. 2+ in intact cardiac myocytes. Circ Res. 74:1994;970-978.
33. Paulus W.J., Kästner S., Pujadas P., Shah A.M., Drexler H., Vanderheyden M. Left ventricular contractile effects of inducible nitric oxide synthase in the human allograft. Circulation. 98:1997;3436-3442.
34. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci USA. 88:1991;1197-1201.
35. Brodde O.E., Michel M.C., Zerkowski H.R. Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure. Cardiovasc Res. 30:1995;570-584.
36. Meßmer U.K., Ankarcrona M., Nicotera P., Brüne B. p53 expression in nitric oxide-induced apoptosis. FEBS Lett. 355:1994;23-26.
37. Pinsky D.J., Cai B., Yang X., Rodriguez C., Sciacca R.R., Cannon P.J. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism of transforming growth factor β J Clin Invest. 95:1995;677-685.
38. Shen W., Xu X., Ochoa M., Zhao G., Wolin M.S., Hintze T.H. Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res. 75:1994;1086-1095.
39. s-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy. J Cardiovasc Pharmacol 1998 (in press).
40. Mery P.F., Pavoine C., Belhassen L., Pecker F., Fischmeister R. Nitric oxide regulates cardiac Ca2+ current Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation . J Biol Chem. 268:1993;26286-26295.